Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma
- 31 December 1992
- journal article
- clinical trial
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 28 (11), 1823-1827
- https://doi.org/10.1016/0959-8049(92)90013-r
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.Journal of Clinical Oncology, 1989
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- Improvements in fluorouracil chemotherapy?Journal of Clinical Oncology, 1989
- Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancerCancer, 1989
- Failure of High-Dose Leucovorin To Improve Therapy With the Maximally Tolerated Dose of 5-Fluorouracil: A Murine Study With Clinical Relevance?JNCI Journal of the National Cancer Institute, 1988
- Severe life-threatening toxicities observed in study using leucovorin with 5-fluorouracil.Journal of Clinical Oncology, 1987
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976